Bayer AG Financials
| BAYN Stock | 19.16 0.26 1.38% |
Bayer |
Understanding current and past Bayer AG Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Bayer AG's financial statements are interrelated, with each one affecting the others. For example, an increase in Bayer AG's assets may result in an increase in income on the income statement.
Please note, the presentation of Bayer AG's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Bayer AG's management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of Bayer AG's management manipulating its earnings.
| Foreign Associate | USA |
| Instrument | Germany Stock View All |
| Exchange | XETRA Stock Exchange |
| ISIN | DE000BAY0017 |
| Business Address | Kaiser-Wilhelm-Allee 1, Leverkusen, |
| Sector | Healthcare |
| Industry | Drug Manufacturers-General |
| Benchmark | Dow Jones Industrial |
| Website | www.bayer.com |
| Phone | 49 214 30 1 |
You should never invest in Bayer AG without having analyzed its financial statements. Do not rely on someone else's analysis or guesses about the future performance of Bayer Stock, because this is throwing your money away. Analyzing the key information contained in Bayer AG's financial statements can give you an edge over other investors and help to ensure that your investments perform well for you.
Bayer AG Key Financial Ratios
There are many critical financial ratios that Bayer AG's investors are exposed to on a daily basis, but they are usually grouped into few meaningful categories from each financial statement that Bayer AG NA reports annually and quarterly.| Return On Equity | 0.13 | |||
| Return On Asset | 0.0576 | |||
| Target Price | 74.7 | |||
| Beta | 1.17 | |||
| Z Score | 0.6 |
Bayer Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Bayer AG's current stock value. Our valuation model uses many indicators to compare Bayer AG value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Bayer AG competition to find correlations between indicators driving Bayer AG's intrinsic value. More Info.Bayer AG NA is number one stock in return on equity category among its peers. It also is number one stock in return on asset category among its peers reporting about 0.44 of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for Bayer AG NA is roughly 2.26 . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Bayer AG's earnings, one of the primary drivers of an investment's value.Bayer AG NA Systematic Risk
Bayer AG's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Bayer AG volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
Incorrect Input. Please change your parameters or increase the time horizon required for running this function. The output start index for this execution was zero with a total number of output elements of zero. The Beta measures systematic risk based on how returns on Bayer AG NA correlated with the market. If Beta is less than 0 Bayer AG generally moves in the opposite direction as compared to the market. If Bayer AG Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Bayer AG NA is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Bayer AG is generally in the same direction as the market. If Beta > 1 Bayer AG moves generally in the same direction as, but more than the movement of the benchmark.
Bayer AG November 28, 2024 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of Bayer AG help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Bayer AG NA. We use our internally-developed statistical techniques to arrive at the intrinsic value of Bayer AG NA based on widely used predictive technical indicators. In general, we focus on analyzing Bayer Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Bayer AG's daily price indicators and compare them against related drivers.
| Information Ratio | (0.25) | |||
| Maximum Drawdown | 18.86 | |||
| Value At Risk | (3.70) | |||
| Potential Upside | 2.85 |
Complementary Tools for Bayer Stock analysis
When running Bayer AG's price analysis, check to measure Bayer AG's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Bayer AG is operating at the current time. Most of Bayer AG's value examination focuses on studying past and present price action to predict the probability of Bayer AG's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Bayer AG's price. Additionally, you may evaluate how the addition of Bayer AG to your portfolios can decrease your overall portfolio volatility.
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios |